{{Rsnum
|rsid=10510634
|Chromosome=3
|position=30305477
|Orientation=plus
|GMAF=0.1455
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 65.6 | 29.5 | 4.9
| HCB | 93.3 | 6.7 | 0.0
| JPT | 69.0 | 28.6 | 2.4
| YRI | 70.5 | 29.5 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 93.3 | 6.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs10510634
|PubMedID=17903298
|Condition=Fasting plasma glucose
|Gene=Intergenic
|Risk Allele=
|pValue=5.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10510634
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903298; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association with diabetes-related traits in the Framingham Heart Study (Initial Sample Size: 1,087 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Fasting plasma glucose.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356531
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10510634
|overall_frequency_n=17
|overall_frequency_d=128
|overall_frequency=0.132812
|n_genomes=15
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}